Healthcare systems around the globe are currently strained with the challenging task of considering inpatient capital projects amidst market pressures, rising expenses, and construction cost escalation. As reported in JD Supra, the quest to generate an appropriate profit margin within this context is proving difficult for many, causing pause for institution leaders when it comes to greenlighting substantial capital commitments.
The COVID-19 pandemic has further exacerbated this issue: national total expenses have spiked by an extraordinary 18% year-to-date (YTD) 2023 compared to YTD 2020. The rising costs seen amidst the global pandemic have become a significant hurdle for healthcare institutions examining the viability of inpatient projects.
Moving forward, healthcare systems may need to adopt innovative strategies and focus on identifying the most viable markets to implement inpatient capital projects. By doing so, the financial feasibility of such programs could be increased substantially. Proactive and strategic management of resources could potentially tip the profit margin in favor of these vital healthcare projects.